(R)-(+)-6'-hydroxy-7'-methoxybergamottin



Compound IDCDAMM00362
Common name(R)-(+)-6'-hydroxy-7'-methoxybergamottin
IUPAC name4-[(E,6R)-6-hydroxy-7-methoxy-3,7-dimethyloct-2-enoxy]furo[3,2-g]chromen-7-one
Molecular formulaC22H26O6

Experimental data

Retention time59.255
Adduct[M+H]+
Actual mz387.184
Theoretical mz387.18
Error9.25
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.1

Identifiers and class information

Inchi keyDXUCGAHPDLXISA-OUZLUOOSNA-N
SmilesO=C1OC=2C=C3OC=CC3=C(OCC=C(C)CCC(O)C(OC)(C)C)C2C=C1
SuperclassPhenylpropanoids and polyketides
ClassCoumarins and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)9
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)386.444
Computed dipole moment(dipole)9.849
Total solvent accessible surface area (SASA)697.396
Hydrophobic component of SASA (FOSA)356.443
Hydrophilic component of SASA (FISA)105.025
Pie component of the SASA (PISA)235.927
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1247.93
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)6.2
Free energy of solvation of dipole (dip^2/V)0.0777315
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0088902
Globularity descriptor (glob)0.803797
Predicted polarizability in cubic angstroms (QPpolrz)40.262
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.471
Predicted octanol/gas partition coefficient (QPlogPoct)18.784
Predicted water/gas partition coefficient (QPlogPw)9.303
Predicted octanol/water partition coefficient (QPlogPo/w)4.061
Predicted aqueous solubility (QPlogS)-5.208
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.371
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.832
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)999.87
Predicted brain/blood partition coefficient (QPlogBB)-1.063
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)494.64
Predicted skin permeability, log Kp (QPlogKp)-1.76
PM3 calculated ionization potential (IP(ev))9.079
PM3 calculated electron affinity (EA(eV))1.081
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)0.401
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)83.622
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O15554KCNN4Intermediate conductance calcium-activated potassium channel protein 4T42724SEA
P22460KCNA5Voltage-gated potassium channel subunit Kv1.5T17569SEA
P22001KCNA3Voltage-gated potassium channel subunit Kv1.3T76914SEA
Q92952KCNN1Small conductance calcium-activated potassium channel protein 1T11911SEA
Q9H2S1KCNN2Small conductance calcium-activated potassium channel protein 2T86271SEA
Q09470KCNA1Voltage-gated potassium channel Kv1.1T85272SEA
Q96RP8KCNA7Voltage-gated potassium channel Kv1.7T84737SEA
P22459KCNA4Voltage-gated A-type potassium channelT15665SEA
P16389KCNA2Voltage-gated potassium channel Kv1.2T19492SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T42724DI0025Alzheimer disease[ICD-11: 8A20]O15554KCNN4
T42724DI0087Chronic pain[ICD-11: MG30]O15554KCNN4
T17569DI0030Angina pectoris[ICD-11: BA40]P22460KCNA5
T76914DI0198Idiopathic inflammatory myopathy[ICD-11: 4A41]P22001KCNA3
T76914DI0351Psoriasis[ICD-11: EA90]P22001KCNA3
T76914DI0352Psoriatic arthritis[ICD-11: FA21]P22001KCNA3
T11911DI0285Myelopathy[ICD-11: 8B42]Q92952KCNN1
T86271DI0285Myelopathy[ICD-11: 8B42]Q9H2S1KCNN2

Copyright © 2025